The EXPLORE MG Registry for Myasthenia Gravis

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT03792659
Status
Recruiting
Apply to this trial

Conditions

  • Myasthenia Gravis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood Sample Draw — OTHER
    Approximately 100 cc (less than 1/2 cup) of blood will be drawn from both groups.

Study Details

The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.

Key Dates

Start date
Mar 30, 2016
Status verified
Nov 2025
Primary completion
Sep 30, 2026
Completion
Oct 30, 2026

Study Design

Enrollment
800 participants (estimated)

Arms

  • Arm: Neurological Outpatients
    Participants in this group will be recruited from the outpatient clinical population at the Yale University Department of Neurology. Treating physicians will make the initial determination of patients' potential eligibility to participate in the study.

Primary Outcome Measure

The number of successful blood draws will be reported at the conclusion of the sample collection [ Time Frame: 8 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Yale-New Haven HospitalNew HavenConnecticut06510
Bailey Munro Sheldon, PhD
[email protected]
203-737-7095
Richard Nowak, MD, MS (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Haven, CT

By research site
Yale-New Haven Hospital· New Haven, CT

Related Studies